Clinical Trials

1 trials

Recent Start date Enrollment

Available × Hyperinsulinism × NET × Clear all

Sponsor

Cancer Type

Endocrine 2 Sarcoma 1 NET 1

Conditions

Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Liposarcoma 1 Insulinoma 1 Hypoglycemia 1 Hyperinsulinism 1 Fibrosarcoma 1 Adenoma, Islet Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡